CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 24 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $298,000 | +3.5% | 16,228 | +3.2% | 0.00% | – |
| Q3 2020 | $288,000 | +7.5% | 15,730 | -12.2% | 0.00% | – |
| Q2 2020 | $268,000 | -4.6% | 17,909 | +1.0% | 0.00% | -100.0% |
| Q1 2020 | $281,000 | +2.2% | 17,735 | +4.6% | 0.00% | – |
| Q4 2019 | $275,000 | +12.2% | 16,949 | +3.0% | 0.00% | – |
| Q3 2019 | $245,000 | -13.1% | 16,459 | -3.5% | 0.00% | -100.0% |
| Q2 2019 | $282,000 | +8.9% | 17,054 | +13.7% | 0.00% | 0.0% |
| Q1 2019 | $259,000 | -4.8% | 14,998 | -2.5% | 0.00% | 0.0% |
| Q4 2018 | $272,000 | +45.5% | 15,377 | +49.2% | 0.00% | – |
| Q3 2018 | $187,000 | -10.1% | 10,303 | -3.3% | 0.00% | – |
| Q2 2018 | $208,000 | +39.6% | 10,650 | -15.5% | 0.00% | – |
| Q1 2017 | $149,000 | -5.7% | 12,601 | +4.7% | 0.00% | – |
| Q4 2016 | $158,000 | -25.5% | 12,033 | -17.7% | 0.00% | -100.0% |
| Q3 2016 | $212,000 | +22.5% | 14,614 | +1.5% | 0.00% | 0.0% |
| Q2 2016 | $173,000 | -13.5% | 14,394 | +54.7% | 0.00% | 0.0% |
| Q4 2015 | $200,000 | -31.3% | 9,307 | +20.2% | 0.00% | 0.0% |
| Q2 2015 | $291,000 | – | 7,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|